Mădălina Maria Merişescu
Biographic Data
| ID | 8261988 |
|---|---|
| NAME | Mădălina Maria Merişescu |
| GIVEN NAMES | Mădălina Maria |
| FAMILY NAME | Merişescu |
| SIGNATURE | MERIŞESCU M M |
| AFFILIATIONS | Carol Davila University of Medicine and Pharmacy |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Remdesivir Efficacy and Tolerability in Children with Covid-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis
In children, coronavirus disease 2019 (COVID-19) starts as a minor illness compared to adults, but during the ongoing COVID-19 pandemic, distinct SARS-CoV-2 variants and subvariants have changed options for therapies in both adults and children, especially for those with comorbidities such as allergies. On 25 April 2022, Remdesivir (RDV), a viral RNA-dependent RNA polymerase inhibitor, was approved by the Food and Drug Administration (FDA) for th…
Clinical and Evolutionary Features of Sars-CoV-2 Infection (Covid-19) in Children, a Romanian Perspective
Background: Given the potential for additional development to clarify a better knowledge of generally influence of COVID-19 upon the pediatric population, the clinical symptoms of SARS-CoV-2 infection in children and adolescents are still being explored. Morbidity in children is characterized by a variable clinical course. Our study’s goal was to compare clinical aspects of 230 pediatric patients who analyzed positive for SARS-CoV-2 and were hosp…
No prominent works on this page.
Clinical and Evolutionary Features of Sars-CoV-2 Infection (Covid-19) in Children, a Romanian Perspective
Background: Given the potential for additional development to clarify a better knowledge of generally influence of COVID-19 upon the pediatric population, the clinical symptoms of SARS-CoV-2 infection in children and adolescents are still being explored. Morbidity in children is characterized by a variable clinical course. Our study’s goal was to compare clinical aspects of 230 pediatric patients who analyzed positive for SARS-CoV-2 and were hosp…
Remdesivir Efficacy and Tolerability in Children with Covid-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis
In children, coronavirus disease 2019 (COVID-19) starts as a minor illness compared to adults, but during the ongoing COVID-19 pandemic, distinct SARS-CoV-2 variants and subvariants have changed options for therapies in both adults and children, especially for those with comorbidities such as allergies. On 25 April 2022, Remdesivir (RDV), a viral RNA-dependent RNA polymerase inhibitor, was approved by the Food and Drug Administration (FDA) for th…
Coronavirus disease 2019 (COVID-19 (2 works) · COVID-19 Clinical Research Studies (2 works) · Disease (2 works) · Infectious disease (medical specialty (2 works) · Medicine (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · 2019-20 coronavirus outbreak (1 work) · Adverse effect (1 work) · Allergy (1 work) · Artificial Intelligence (1 work)